Mikko Tukiainen

Title: Mikko Tukiainen: Innovator in Oncogenic Fusion Identification

Introduction

Mikko Tukiainen is a notable inventor based in Kaarina, Finland. He has made significant contributions to the field of oncology through his innovative work. His research focuses on identifying candidate signs indicative of oncogenic fusions, which can play a crucial role in cancer diagnosis and treatment.

Latest Patents

Mikko Tukiainen holds a patent titled "Identification of candidate signs indicative of an NTRK oncogenic fusion." This invention relates to a computer-implemented method, a system, and a non-transitory computer-readable storage medium. It aims to determine a probability value from patient data, indicating the likelihood of a subject patient suffering from cancer caused by a mutation of the neurotrophic receptor tyrosine kinase (NTRK) gene. He has 1 patent to his name.

Career Highlights

Mikko Tukiainen is associated with Viherasema Oy, where he applies his expertise in oncology and technology. His work has the potential to impact cancer treatment significantly, providing healthcare professionals with valuable tools for patient assessment.

Collaborations

Mikko collaborates with talented individuals such as Arndt Schmitz and Eren Metin Elci. Their combined efforts contribute to advancing research in the field of cancer diagnostics.

Conclusion

Mikko Tukiainen is a pioneering inventor whose work in identifying oncogenic fusions is paving the way for improved cancer diagnosis and treatment. His contributions are vital to the ongoing fight against cancer, showcasing the importance of innovation in healthcare.